AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
16 hedge funds and large institutions have $18M invested in Ambrx Biopharma Inc in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$109K | |
| 2 | +$87.4K | |
| 3 | +$39.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$25K |
| 5 |
Millennium Management
New York
|
+$22.5K |
Top Sellers
| 1 | -$554K | |
| 2 | -$325K | |
| 3 | -$309K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$165K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$5.66K |